Immupharma Share Discussion Threads

[dillydally2] 22/8/2022 15:24

Twitter pumpers claiming allSorts here

[david gruen] 22/8/2022 14:59

No pumpers here Dally. Check the history here and on social media platforms. If you've missed the boat, deal with it.

[dillydally2] 22/8/2022 14:57

Pumpers going for it like it's almost a given for fda approval if it is notThis will tank 50/60% Dnt risk it these pumpers are very very dangerous

[1bond] 22/8/2022 13:49

Despite the doom mongers, I do think we have turned a corner with the management team and the future signs look encouraging. Still issues to resolve, too many warrants for one, although with a good share price that could be a positive longer term. Still the most undervalued company on AIM with a fully funded Phase III asset

[neo26] 22/8/2022 12:35

Nobby bye..

[nobbygnome] 22/8/2022 12:12

Hi Clint👋Ԁ75;

Good to see the buys. Keep them coming so I can get out on the spike!

[bloomberg2] 22/8/2022 12:10

Might see a bit of 7s today boys

[neo26] 22/8/2022 12:05

Buyers comin in..Get phase 3 approved this can do 200%.Mkt cap only 20m.

[bloomberg2] 22/8/2022 12:03

All aboard the skylark

[clintdavid1] 19/8/2022 13:26

Nobbby-filtered-feel better already

[zxie] 16/8/2022 08:24

INSP shares jump soon

[thordon] 15/8/2022 22:21

Assuming that directors have spare cash

[nobbygnome] 15/8/2022 12:05

That’s actually a very good point…

[supernumerary] 11/8/2022 09:27

I also think it looks a decent outcome, but I guess they'll all hit the market again the instant there's a sniff of a rise.

[1bond] 11/8/2022 07:40

In this market it looks a good result, over £1m raised from the broker option and placing. I don't see many other companies raising money at the moment

[nobbygnome] 11/8/2022 07:11

So not that much appetite for the broker option fund raising as less than 75% was applied for and £100k of that was directors. Ho hum….

[mudbath] 10/8/2022 12:14

The dealings this morning are 100% buys if marked at 5.22p or above; with 400k of these being mine.

[nobbygnome] 10/8/2022 11:07

But the drug still won’t work…

[nobbygnome] 10/8/2022 11:06

>> llol

I’m not sure even Tim could come out with a complete and utter lie like that when the FDA is involved. And I can assure you that if I lose all the small amount I currently have invested here, I wouldn’t lose one second of sleep over it. They were actually the most open they have ever been in that meeting warts and all so even I have to commend them for that.

[1ultimate] 10/8/2022 11:02

Some big sells today, what’s happening? Someone know something?

[lord loads of lolly] 10/8/2022 10:58

nobby - I'm baffled why a) you're confused by Tim's comments & b) you take his assertion at face value that FDA approval is a slam dunk. You've said all along he's only in it for himself and that you wouldn't trust him as far as you could throw him. So why give him any credence now? Could it be because you've bought back in, hoping to make a quick profit on approval (if it's granted)? IMM has a history of failing to deliver on what everyone thought was a racing certainty. Here's hoping - for your sake - Tim hasn't led you down the garden path yet again. The latest placing certainly knackered many people's recent purchase timing.

[colsmith] 10/8/2022 10:19

Nobby - what he said is that they have FDA approval for P3 start but the FDA wanted a PK study and company took view it was prudent to do PK first as FDA wanted it and they were keen to not jeopardise relationship with FDA as they are the regulator. Anyhow I guess is the 29th and FDA response letter ,presumably on PK study results, is the next leg up or down on share price